Paroxetine
Associated Hepatotoxicity: A Report of 3 Cases and a
Review of the Literature
T. Azaz-Livshits, A.
Hershko, E. Ben-Chetrit
1 Department
of Medicine and Clinical Pharmacology, Hadassah
University Hospital, Jerusalem,
Israel
We recently encountered 3 patients who had developed
reversible paroxetine-associated hepatotoxicity. Two of the
patients were over 80 years old and their hepatitis was
accompanied by hyponatremia. In the third case, hepatitis was
associated with multiple organ failure and the
co-administration of trazodone. Here, we will discuss the
possible role of preexisting risk factors in the development
of paroxetine hepatotoxicity and review the relevant
literature.